Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China · Delayed Price · Currency is CNY 37.96
+1.36 (3.72%)
At close: Jun 18, 2026
SHA:688192 Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, SHA:688192 stock has a consensus rating of "Strong Buy" and an average price target of ¥91.38. The average 1-year stock price forecast is 140.73% higher than the current stock price, while the lowest is ¥83.00 (+118.65%) and the highest is ¥99.75 (+162.78%).
Price Target: ¥91.38 (+140.73%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for SHA:688192 stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Jan '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 4 | 4 | 4 | 4 |
Financial Forecast
Revenue This Year
1.34B
from 801.14M
Increased by 67.82%
Revenue Next Year
2.11B
from 1.34B
Increased by 57.12%
EPS This Year
-0.54
from -1.89
EPS Next Year
0.72
from -0.54
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CNY.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 1.5B | ||
| Avg | 1.3B | ||
| Low | 1.2B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 90.1% | ||
| Avg | 67.8% | ||
| Low | 44.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | -0.54 | ||
| Low | - |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |